Johnson & Johnson (JNJ) Tops Q3 EPS by 23c, Beats on Revenue

Johnson & Johnson (NYSE: JNJ) reported Q3 EPS of $2.42, $0.23 better than the analyst estimate of $2.19. Revenue for the quarter came in at $22.5 billion versus the consensus estimate of $22.17 billion.

For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat